ARCHIVES

FDA, NCI Seek Compromise On Survival Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 24 | June 16, 1989

Download PDF Visit The Full Archive

Related Articles

ACS Chief Medical Officer Brawley Urges Audit Of I-ELCAP Lung Screening Data.

September 26, 2008

Funding Opportunities

December 6, 2002

In Brief: Peter Jones Is Interim director of USC’s Norris; NIAMS Funds Skin Disease Corse At Yale, Texas

January 1, 1993

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

September 28, 2007

Regulations Threaten Clinical Trials Higgins contends

May 16, 1980

Tip O’Neill Testifies As Cancer Survivor At Hearing Called To Renew Commitment To ‘War On Cancer’

April 26, 1991